Health Condition 1: I059- Rheumatic mitral valve disease, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients undergoing elective Mitral valve replacement without Tricuspid regurgitation or Mild to moderate Tricuspid regurgitation.
Exclusion criteria
Exclusion criteria: Patients With persistent left superior vena cava, total anomalous pulmonary venous return, coronary atrioventricular fistula, anomalous hepatic venous drainage, coronary sinus thrombosis and any postoperative coronary sinus obstruction. Patients With Severe Tricuspid regurgitation or eccentric Tricuspid regurgitation jet towards Coronary Sinus Patients requiring concomitant Aortic valve surgery or Coronary artery bypass graft Patients With severe Left ventricular Dysfunction. Patients in whom Trans esophageal echocardiography is contraindicated.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To explore the correlation between coronary sinus diameter and right ventricular dysfunction at different intervals in the postoperative period in patients who have undergone mitral valve surgery, as well as its relationship to right ventricular myocardial performance index. Timepoint: Coronary sinus diameter is measured pre operatively and post operatively 24 hours after shifting to ICU | — |
Secondary
| Measure | Time frame |
|---|---|
| Investigating the association between Vasoactive inotrope score score (VIS max), mechanical ventilation duration, ICU stay, hospital stay, & mortality is the secondary objective. Timepoint: VIS score measured at baseline, 12 hours, 24 hours & 48 hours after shifting to ICU | — |
Countries
India
Contacts
UN Mehta Institute of Cardiology and Research Centre